Clinical trials of inhaled version of drug to treat COVID-19 to begin
The company behind the only drug approved by the U.S. Food and Drug Administration for treatment of COVID-19 announced Monday plans to begin clinical trials of an inhaled version of the drug, which, if proven beneficial, could make it easier to administer and treat people earlier. In an open letter posted to Gilead Sciences website … Continued